-
When IRBs approve a clinical trial site's informed consent documents, they often have no way of knowing how the informed consent process is played out at the site.
-
The National Cancer Institute (NCI) of Bethesda, MD, decided to address a deficit in quality of biospecimens collected for research purposes with the recent publication of improved recommendations.
-
IRBs and investigators continually look for ways to improve the informed consent (IC) process. One novel idea is to create an interactive informed consent program that serves a dual purpose of providing education to patients and trial participants.
-
For the first time, newly proposed guidance puts a number and a cost to the respirators needed to protect health care workers during an influenza pandemic: 480 respirators at a cost of about $240 to protect a single employee, or a single reusable elastomeric respirator with three filters at a cost of $40 per employee.
-
If you could give health care workers the ideal respirator, what would it look like? For the first time, an interagency task force is considering that question in a project they hope will result in a more effective, less cumbersome respirator perhaps one that doesn't require fit-testing.
-
It has been 10 years since Johns Hopkins Hospital in Baltimore created a latex task force to address the growing numbers of latex-sensitive employees.
-
Are your employees too busy to be safe? Too stuck in their old way of doing things to use new safety equipment?
-
The Centers for Disease Control and Prevention is requesting comments on its proposed guidance on antiviral prophylaxis during an influenza pandemic.
-
"At what price is cure a goal? And what price does hope carry?" Lindsay E. Rockwell, MD, a Northampton, MA oncologist, wrote in a 2007 JAMA article.
-
Genetics research tells us that every person has as many as six or even more genetic mutations placing him or her at risk for some disease.
